Recently, rising evidence has demonstrated the role of the intestinal hormone Neurotensin (NT) in the development of obesity and its related cardio-metabolic disorders such as type 2 diabetes, non-alcoholic fatty liver disease (NAFLD), and CVDs6–12. Here, NTS is linked to metabolic dysfunction-associated steatotic liver disease.